SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells
Emily Piccione(California Institute for Regenerative Medicine), Ravindra Majeti(Stanford University)
Cited by 50
Related Papers
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
|Cancer Discovery|2022|59
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors
|Nature Biotechnology|2024|56
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience
|Leukemia & lymphoma/Leukemia and lymphoma|2020|29
Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119
|Blood Cancer Discovery|2024|17